Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy

AIDS

Volumn 13, Issue 8, 1999, Pages 927-933

  de Martino, M ^a   Galli, L ^a   Tovo, P A ^b   Gabiano, C ^b   Zappa, M ^c   Osimani, P ^d   Zizzadoro, P ^d   de Mattia, D ^d   Ruggeri, M ^d   Lanari, M ^d   Dalla Vecchia, S ^d   Masi, M ^d   Miniaci, A ^d   Baldi, F ^d   Dell'Erba, G ^d   Battisti, L ^d   Duse, M ^d   Crispino, P ^d   Uberti, E ^d   Bresciani, E ^d   Chiriaco P G ^d   Pintor, C ^d   Dedoni, M ^d   Loriano, D ^d   Dessi C ^d   Anastasio, L ^d   Sabatino, G ^d   Sticca, M ^d   Berrino, R ^d   Lodato, A ^d   Vierucci, A ^d   Farina, S ^d   de Luca, M ^d   de Maria, A ^d   Fioredda, F ^d   Boni, S ^d   Marazzi, M G ^d   Pontali, E ^d   Forni, G L ^d,d   Gotta, C ^d   Tasso, L ^d   Gambaretto, G ^d   Meo, A ^d   Plebani, A ^d   Pinzani, R ^d   Salvini, F ^d   Marchisio, P ^d   Massironi, E ^d   Tornaghi, R ^d   Zuccotti, G V ^d   Riva, S ^d   de Carlis, S ^d   Ferraris, G ^d   Bucceri, A ^d   Lipreri, R ^d   Cellini, M ^d   Guarino, A ^d   Pignata, C ^d   Tarallo, L ^d   Giaquinto, C ^d   Ruga, E ^d   Rampon, O ^d   Romano, A ^d   Benaglia, G ^d   Caselli, D ^d   Maccabruni, A ^d   Consolini, R ^d   Palla, G ^d   Antonellini, A ^d   Magnani, C ^d   Cecchi, T ^d   Castelli Gattinara, G ^d   Bernardi, S ^d   Cancrini, C ^d   Fundaro C ^d   Genovese, O ^d   Rendeli, C ^d   Timpano, C ^d   Anzidei, G ^d   Catania, S ^d   Stegagno, M ^d   Mazza, A ^d   Salvatore, C ^d   Scolfaro, C ^d   Palomba, E ^d   Riva, C ^d   Pellegatta, A ^d   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d NONE

Author keywords

Disease progression; Perinatal infection; Zidovudine; Zidovudine in pregnancy

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ARTICLE; BIRTH WEIGHT; CHILD; DELIVERY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PERINATAL INFECTION; PNEUMOCYSTIS PNEUMONIA; PREGNANCY; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; SURVIVAL RATE; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ZIDOVUDINE;

EID: 0033043731     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199905280-00008     Document Type: Article

References (32)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994, 331:1173-1180.
2. Simonds RJ, Steketee R, Nesheim S, et al. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. AIDS 1998, 12:301-308.
3. Mayaux MJ, Teglas JP, Mandelbrot L, et al. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France. J Pediatr 1997, 131:857-862.
4. de Martino M, Galli L, Chiarelli F, Rossi ME, Vierucci A. Do nucleoside analogues directly influence T-lymphocyte subset counts? The pediatric model. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:391-392.
5. Simpson BJ, Shapiro ED, Andiman WA Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:145-152.
6. Wade NA, Birkhead GS, Warren BI, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998, 339:1409-1414.
7. Ferrazin A, de Maria A, Gotta C, et al. Zidovudine therapy of HIV-1 infection during pregnancy: assessment of the effect on the newborns. J Acquir Immune Defic Syndr 1993, 6:376-379.
8. Galli L, Mannelli F, Azzari C, et al. Combined cesarean section and antiretroviral treatment in pregnancy as a strategy in preventing mother-to-child HIV-1 transmission. Int J Immunopath Ph 1997, 10:236.
9. de Martino M, Tovo P-A, Galli L, et al. Prognostic significance of immunologic changes in 675 infants perinatally exposed to human immunodeficiency virus. J Pediatr 1991, 119:702-709.
10. de Martino M, Tovo P-A, Tozzi AE, et al. HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding. AIDS 1992, 6:991-997.
11. Tovo P-A, de Martino M, Gabiano C, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992, 339:1249-1253.
12. de Martino M, Tovo P-A, Galli L, et al. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994, 343:191-195.
13. Galli L, de Martino M, Tovo P-A, et al. Onset of clinical signs in children with HIV-1 perinatal infection. AIDS 1995, 9:455-461.
14. Tovo P-A, de Martino M, Gabiano C, et al. Mode of delivery and gestational age influence perinatal HIV-1 transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:88-94.
15. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morb Mortal Wkly Rep 1994, 43(RR-12):1-10.
16. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1993, 41(RR-17):1-17.
17. Pliner V, Weedon J, Thomas PA, et al. Incubation period of HIV-1 in perinatally infected children. AIDS 1998, 12:759-766.
18. Blanche S, Mayaux M-J, Rouzioux C, et al. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994, 330:308-312.
19. Centers for Disease Control and Prevention. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Morb Mortal Wkly Rep 1998, 47(RR-2):1-30.
20. Coll O, Hernandez M, Boucher CAB, et al. Vertical HIV-1 transmission correlates with a high maternal viral load at delivery. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:26-30.
21. Thea DM, Steketee RW, Pliner V, et al. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. AIDS 1997, 11:437-444.
22. + cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. J Pediatr 1997, 130:890-897.
23. Mofenson LM, Korelitz J, Meyer WA, et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. J Infect Dis 1997, 175:1029-1038.
24. Shearer WT, Quinn TC, LaRussa P, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N Engl J Med 1997, 336:1337-1342.
25. Leriche-Guerin K, Trabaud MA, Cotte L, et al. Correlation between antiretroviral resistance mutations, biological parameters, and clinical evolution in zidovudine-treated patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 1997, 16:660-668.
26. Melvin AJ, Burchett SK, Watts DH, et al. Effect of pregnancy and zidovudine therapy on viral load in HIV-1 infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:232-236.
27. Eastman PS, Shapiro DE, Coombs RW, et al. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in Pediatric AIDS Clinical Trials Group Protocol 076. J Inf̄ect Dis 1998, 177:557-564.
28. Blanche S, Newell M-L, Mayaux M-J, for The French Pediatric: HIV Infection Study Group and European Collaborative Study. Morbidity and mortality in European children vertically infected by HIV-1. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:442-450.
29. Dickover RE, Dillon M, Gillette SG, et al. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994, 170:1279-1284.
30. Kuhn L, Abrams EJ, Mathenson PB, et al. Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. AIDS 1997, 11:429-435.
31. Shafer RW, Winters MA, Palmer S, Meringan TC. Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients. Ann Intern Med 1998, 128:906-911.
32. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Morb Mortal Wkly Rep 1998, 47(RR-4):1-43.